Intramyocardial Septal Radiofrequency Ablation System
Clinical- Indications
- Hypertrophic obstructive cardiomyopathy
Company intelligence / Profile preview
Suzhou Sinus Medical Technologies develops medical devices for the treatment of arrhythmias, including a chemical ablation apparatus. The company holds patents related to these technologies but there is no public information about clinical trial results or regulatory approvals as of now[3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzhou Sinus Medical Technologies.